Alzheimer's Assocation Research only
All of
  • Go to
  • Research Center
  • AAIC
  • Journal
  • Grants
  • TrialMatch
  • Press
  • Donate
  • Contact Us
Science and Progress
Clinical Trials
Funding and Collaboration
You can Help
Stay Current
Video and Resources

Text Size

Small text Medium text Large text

World Wide Alzheimer's Disease Neuroimaging Initiative

Argentina ADNI

Argentina ADNI (Arg-ADNI) has launched the first South American ADNI effort to acquire data comparable to the information gathered throughout other WW-ADNI centers. The Arg-ADNI team are in the process of enrolling volunteers for this study; their goals for enrollment are thirty volunteers with Mild Cognitive Impairment, fifteen volunteers with Alzheimer's disease, and fifteen health controls. Arg-ADNI shares the WW-ADNI goal of developing biomarkers for Alzheimer's disease to identify possible predictive measures of the disease progression. This includes establishment and validation of MRI and PET images, cerebral spinal fluid measures and blood biomarkers.

For more information about Argentina ADNI, click here.

Alzheimer's Association International Conference | July 16-20, 2017, London, England

Abstract Submissions Now Open

The Scientific Program Committee is now accepting submissions for poster
presentations, oral presentations and featured research sessions.